Versatile and on-demand biologics co-production in yeast
The ability to combine the production of multiple biologics into a single ‘on demand’ system could help in situations where resources are limited. Here the authors demonstrate a proof-of-concept approach for the co-production of three biologics, allowing singular, mixed and combination drug products...
Guardado en:
Autores principales: | Jicong Cao, Pablo Perez-Pinera, Ky Lowenhaupt, Ming-Ru Wu, Oliver Purcell, Cesar de la Fuente-Nunez, Timothy K. Lu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6a69703c022e40fcb360d33fd32745bf |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Synthetic biology and microbioreactor platforms for programmable production of biologics at the point-of-care
por: Pablo Perez-Pinera, et al.
Publicado: (2016) -
Evolutionary systems biology of amino acid biosynthetic cost in yeast.
por: Michael D Barton, et al.
Publicado: (2010) -
Engineering yeast for the production of breviscapine by genomic analysis and synthetic biology approaches
por: Xiaonan Liu, et al.
Publicado: (2018) -
Quantitative analysis of the effective functional structure in yeast glycolysis.
por: Ildefonso M De la Fuente, et al.
Publicado: (2012) -
Versatile whole-organ/body staining and imaging based on electrolyte-gel properties of biological tissues
por: Etsuo A. Susaki, et al.
Publicado: (2020)